Category: Research

Diabetes_UK_Logo

Diabetes UK to Fund New Diabetes Research

Diabetes UK announced that it would be dedicating almost £750,000 ($1,200,000) to four new research projects looking to understand the causes of diabetes, help with its day-to-day management and protect against its complications. "We are delighted to be supporting this new research and hope that it will bring benefit and improvements for people living...
0 Shares
NIH Logo

First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines

The National Institute of Health (NIH) announced the approval of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. Children's Hospital Boston developed 11 of the approved lines and Rockefeller University in New York City developed two of the approved lines....
0 Shares

Old Drug May Hold New Hope

A drug commonly used to treat non-Hodgkin's lymphoma and rheumatoid arthritis now also shows some promise in helping patients newly diagnosed with type 1 diabetes. The drug, rituximab (Rituxan) helped patients continue to produce some of their own insulin...
0 Shares
Tikomed Logo

Success Rate of Islet Cells Transplants May Improve With New Treatment

TikoMed AB, a Swedish biotechnology company focused on development and commercialization of innovative treatments for immune diseases and cell therapies, announced that IBsolvMIR® has been granted orphan drug designation for the prevention of graft rejection of pancreatic islet transplantation by the U.S. Food and Drug Administration (FDA)...
0 Shares
Spherix Logo

Spherix Inc. Announces Positive Results for Type 2 Therapy

Spherix Inc., an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, and biotechnology companies, announced positive interim Phase 3 clinical results for the use of D-tagatose for treatment of type 2 diabetes patients...
0 Shares

Insulin Production Mechanism Discovered Which May Lead To Better Treatment of Diabetes

Researchers at the Hebrew University in Jerusalem, in collaboration with Japanese and American researchers, have discovered a mechanism of insulin production within the pancreas. The team, led by Prof. Yuval Dor, explored the role of LKB1, a gene involved in many cellular functions, whose role in the pancreas had not been examined before.
0 Shares
Compugen logo

Diabetes Genetic Marker Discovered

Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes. A predisposition marker is of particular value in type 2 diabetes since lifestyle plays an important role in the disease. Following diagnosis, those at high-risk might benefit from more aggressive management either through changes in lifestyle or drug treatment.
0 Shares